Moderna has settled related lawsuits that accused it of misusing Alnylam Pharmaceuticals' patented technology in its COVID-19 ...

In the most recent trading session, Moderna (MRNA) closed at $25.51, indicating a +2.03% shift from the previous trading day.

Moderna is producing its first made-in-Canada COVID-19 shots at facilities in Laval, Que. and Cambridge, Ont. The Laval ...

The World Health Organisation claims their roll-out prevented 14.4 million deaths worldwide in their first year, with some ...

"As US funding falters, mRNA cancer vaccine pioneers face new hurdles" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

Using the metaphor of a "strategic technology tree," the VAST emphasised that basic research serves as the nourishing ...

I can’t say I was surprised, but it didn’t take long for readers to jump at the bait this month when I wrote that for the first time, I had tested positive for COVID-19 despite having been regularly ...

Biotech entrepreneurship must run in the blood for the Langers.   | Renowned biotech veteran Robert Langer is the executive ...

The promise of messenger RNA (mRNA) has moved far beyond its pandemic-era spotlight. In oncology, mRNA has emerged as a ...

Novavax, Inc.’s outlook improves with a Sanofi partnership and upgraded 2025 revenue guidance. Click here to find out why ...